Inhibikase Therapeutics: Q3 Earnings Insights

By: via Benzinga
Inhibikase Therapeutics (NASDAQ:IKT) reported its Q3 earnings results on Tuesday, November 14, 2023 at 04:20 PM. Here's what investors ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.